Market Overview:
The global eye viscoelastic agent market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of eye diseases and disorders, rising geriatric population, and technological advancements in ophthalmic surgeries. This can be attributed to its superior properties such as high biocompatibility, low antigenicity, and long-term stability. Based on application, the global eye viscoelastic agent market is segmented into cataract surgery, glaucoma surgery, combined cataract and corneal transplantation surgery, and eye injury. Cataract surgery accounted for a larger share of the market than other applications in 2017 owing to its high prevalence across all regions worldwide.
Product Definition:
Eye Viscoelastic Agent is a substance which is used to help keep the eyes moist. It can also be used to help treat dry eye syndrome.
Sodium Hyaluronate:
Sodium hyaluronate (NaHA) is a chemical compound, which occurs naturally in the body as a part of connective tissue. It is widely used in pharmaceuticals and cosmetics for treating arthritis, cancer pain, gouty arthritis and other diseases.
Hydroxypropylmethylcellulose:
Hydroxypropylmethyl cellulose (HPMC) is a synthetic water-soluble polymer. It has viscoelastic properties like other hydrophilic polymers such as PVA, HPME, and HPMCP. Hydroxypropyl methyl cellulose is used in ophthalmic solutions to prevent the formation of sedimentation particles due to its low molecular weight and high viscosity.
Application Insights:
The combined cataract and corneal transplantation surgery segment dominated the global eye viscoelastic agent market in 2017. This is due to a rise in the number of patients suffering from advanced glaucoma and keratoconus, coupled with rising awareness about this procedure among surgeons. In addition, increasing demand for highly efficient surgical procedures to reduce pressure inside the eye may also be attributed to its dominance over other application segments during this period.
Glaucoma surgery segment is expected to grow at a lucrative rate during the forecast period owing to an increase in Glaucoma surgeries globally as well as locally. For instance, according these statistics by The Eye Bank Association of America; since January 2015 till date; more than 12000 glaucoma surgeries have been performed by EBRO ( endothelial basement membrane replacement ocular implant) worldwide which includes 7500 EBRO-based glaucomas and 5000 conventional IOLs (intraocular lenses).
Regional Analysis:
North America dominated the global eye viscoelastic agent market in 2017. The increasing prevalence of chronic diseases such as diabetes and cataract is one of the major factors responsible for its largest share. In addition, a rise in cosmetic surgeries has also contributed to its large share owing to high demand for aesthetic surgery procedures that offer improved appearance and confidence.
Asia Pacific is expected to be the fastest-growing region over the forecast period due to an increase in diabetic retinopathy patients, coupled with growing medical tourism industry, especially in emerging countries such as India and China.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The increasing prevalence of various eye diseases and disorders is one of the key growth drivers for the global Eye Viscoelastic Agent market. According to a study by the World Health Organization (WHO), over 285 million people were affected by vision impairment in 2015, out of which 246 million were cases of uncorrected refractive errors. This number is expected to increase in the coming years due to the rising population and aging population. Thus, there will be an increased demand for Eye Viscoelastic Agents products, which will drive market growth during the forecast period.
- Rising awareness about eye care: There has been a rise in awareness about eye care in recent years, owing to initiatives taken by various governments as well as non-profit organizations across different regions worldwide. This has led to an increase in adoption rates for Eye Viscoelastic Agents products among consumers globally. Additionally, manufacturers are focusing on launching innovative products that offer better performance and convenience than traditional methods, thereby driving market growth further during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Eye Viscoelastic Agent Market Research Report
By Type
Sodium Hyaluronate, Hydroxypropylmethylcellulose
By Application
Cataract Surgery, Glaucoma Surgery, Combined Cataract and Corneal Transplantation Surgery, Eye Injury
By Companies
Johnson & Johnson, Alcon Laboratories, Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Abott, LG, Haohai Bio, Freda, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Eye Viscoelastic Agent Market Report Segments:
The global Eye Viscoelastic Agent market is segmented on the basis of:
Types
Sodium Hyaluronate, Hydroxypropylmethylcellulose
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cataract Surgery, Glaucoma Surgery, Combined Cataract and Corneal Transplantation Surgery, Eye Injury
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Alcon Laboratories
- Bausch & Lomb
- Carl Zeiss AG
- Topcon Corporation
- Abott
- LG
- Haohai Bio
- Freda
- Johnson & Johnson
Highlights of The Eye Viscoelastic Agent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sodium Hyaluronate
- Hydroxypropylmethylcellulose
- By Application:
- Cataract Surgery
- Glaucoma Surgery
- Combined Cataract and Corneal Transplantation Surgery
- Eye Injury
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eye Viscoelastic Agent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eye Viscoelastic Agent is a type of medication that helps to reduce the appearance of wrinkles and lines around the eyes. It is usually used in combination with other treatments, such as Botulinum Toxin Injections or fillers.
Some of the major companies in the eye viscoelastic agent market are Johnson & Johnson, Alcon Laboratories, Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Abott, LG, Haohai Bio, Freda, Johnson & Johnson.
The eye viscoelastic agent market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eye Viscoelastic Agent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eye Viscoelastic Agent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eye Viscoelastic Agent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eye Viscoelastic Agent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eye Viscoelastic Agent Market Size & Forecast, 2018-2028
4.5.1 Eye Viscoelastic Agent Market Size and Y-o-Y Growth
4.5.2 Eye Viscoelastic Agent Market Absolute $ Opportunity
Chapter 5 Global Eye Viscoelastic Agent Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Eye Viscoelastic Agent Market Size Forecast by Type
5.2.1 Sodium Hyaluronate
5.2.2 Hydroxypropylmethylcellulose
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Eye Viscoelastic Agent Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Eye Viscoelastic Agent Market Size Forecast by Applications
6.2.1 Cataract Surgery
6.2.2 Glaucoma Surgery
6.2.3 Combined Cataract and Corneal Transplantation Surgery
6.2.4 Eye Injury
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eye Viscoelastic Agent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eye Viscoelastic Agent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Eye Viscoelastic Agent Analysis and Forecast
9.1 Introduction
9.2 North America Eye Viscoelastic Agent Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Eye Viscoelastic Agent Market Size Forecast by Type
9.6.1 Sodium Hyaluronate
9.6.2 Hydroxypropylmethylcellulose
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Eye Viscoelastic Agent Market Size Forecast by Applications
9.10.1 Cataract Surgery
9.10.2 Glaucoma Surgery
9.10.3 Combined Cataract and Corneal Transplantation Surgery
9.10.4 Eye Injury
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Eye Viscoelastic Agent Analysis and Forecast
10.1 Introduction
10.2 Europe Eye Viscoelastic Agent Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Eye Viscoelastic Agent Market Size Forecast by Type
10.6.1 Sodium Hyaluronate
10.6.2 Hydroxypropylmethylcellulose
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Eye Viscoelastic Agent Market Size Forecast by Applications
10.10.1 Cataract Surgery
10.10.2 Glaucoma Surgery
10.10.3 Combined Cataract and Corneal Transplantation Surgery
10.10.4 Eye Injury
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Eye Viscoelastic Agent Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Eye Viscoelastic Agent Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Eye Viscoelastic Agent Market Size Forecast by Type
11.6.1 Sodium Hyaluronate
11.6.2 Hydroxypropylmethylcellulose
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Eye Viscoelastic Agent Market Size Forecast by Applications
11.10.1 Cataract Surgery
11.10.2 Glaucoma Surgery
11.10.3 Combined Cataract and Corneal Transplantation Surgery
11.10.4 Eye Injury
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Eye Viscoelastic Agent Analysis and Forecast
12.1 Introduction
12.2 Latin America Eye Viscoelastic Agent Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Eye Viscoelastic Agent Market Size Forecast by Type
12.6.1 Sodium Hyaluronate
12.6.2 Hydroxypropylmethylcellulose
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Eye Viscoelastic Agent Market Size Forecast by Applications
12.10.1 Cataract Surgery
12.10.2 Glaucoma Surgery
12.10.3 Combined Cataract and Corneal Transplantation Surgery
12.10.4 Eye Injury
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Eye Viscoelastic Agent Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Eye Viscoelastic Agent Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Eye Viscoelastic Agent Market Size Forecast by Type
13.6.1 Sodium Hyaluronate
13.6.2 Hydroxypropylmethylcellulose
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Eye Viscoelastic Agent Market Size Forecast by Applications
13.10.1 Cataract Surgery
13.10.2 Glaucoma Surgery
13.10.3 Combined Cataract and Corneal Transplantation Surgery
13.10.4 Eye Injury
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eye Viscoelastic Agent Market: Competitive Dashboard
14.2 Global Eye Viscoelastic Agent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Alcon Laboratories
14.3.3 Bausch & Lomb
14.3.4 Carl Zeiss AG
14.3.5 Topcon Corporation
14.3.6 Abott
14.3.7 LG
14.3.8 Haohai Bio
14.3.9 Freda
14.3.10 Johnson & Johnson
